• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

    2021-05-10 08:56:48LingJiaGaoYuQinZhuLiangXu
    Hepatoma Research 2021年4期

    Ling-Jia Gao, Yu-Qin Zhu, Liang Xu

    School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.

    Abstract Nonalcoholic fatty liver disease is a major contributor to chronic liver disease worldwide, and 10%-20% of nonalcoholic fatty liver progresses to nonalcoholic steatohepatitis (NASH). Astaxanthin is a kind of natural carotenoid, mainly derived from microorganisms and marine organisms. Due to its special chemical structure,astaxanthin has strong antioxidant activity and has become one of the hotspots of marine natural product research.Considering the unique chemical properties of astaxanthin and the complex pathogenic mechanism of NASH,astaxanthin is regarded as a significant drug for the prevention and treatment of NASH. Thus, this review comprehensively describes the mechanisms and the utility of astaxanthin in the prevention and treatment of NASH from seven aspects: antioxidative stress, inhibition of inflammation and promotion of M2 macrophage polarization,improvement in mitochondrial oxidative respiration, regulation of lipid metabolism, amelioration of insulin resistance, suppression of fibrosis, and liver tumor formation. Collectively, the goal of this work is to provide a beneficial reference for the application value and development prospect of astaxanthin in NASH.

    Keywords: Nonalcoholic fatty liver disease, astaxanthin, fibrosis, insulin resistance, mitochondrial dysfunction,oxidative stress

    INTRODUCTION

    Nonalcoholic fatty liver disease (NAFLD) has become one of the most prevalent forms of chronic liver disease in most countries, and is frequently associated with obesity, metabolic syndrome, and type 2 diabetes[1]. NAFLD is characterized by the accumulation of triglyceride (TG) fats by more than 5% to 10% of the liver weight in the absence of superfluous alcohol consumption. Nonalcoholic steatohepatitis (NASH),an advanced form of NAFLD, is characterized by hepatocellular steatosis, lobular inflammation, and fibrosis, and may lead to liver cirrhosis and hepatocellular carcinoma[2-4]. According to global epidemiological research, the global prevalence of NAFLD is increasing year by year and reached approximately 25% by 2016[5-7]. Studies have shown that NAFLD is rapidly increasing as an indicator for liver transplantation, and its incidence in the United States is currently as high as one-third of the total population[8].

    For the pathogenesis of NASH, the widely accepted theory is the “second or multiple hits” hypothesis[9,10], as show as Figure 1. Although insulin resistance, enhanced oxidative stress followed by lipid peroxidation, and rising proinflammatory cytokine release are believed to be the major causes of progression to NASH[11,12], the concrete mechanisms remains obscure. Currently, NAFLD is considered to be an integral part of metabolic syndrome with insulin resistance as the central risk factor. Metabolic syndrome is often characterized by oxidative stress, a disturbance in the balance between the production of reactive oxygen species (ROS) and antioxidant defenses[13].

    Currently, several pharmacological agents, such as metformin, thiazolidinediones, and vitamin E have been tested as treatments for NASH in clinical trials[14-16]. However, these agents are generally insufficient to ameliorate liver inflammation and fibrosis, and have raised safety concerns. Therefore, a potential therapy with minimal adverse effects is eagerly awaiting. It has recently become clear that the effects of astaxanthin go beyond its antioxidant properties. Astaxanthin is a xanthophyll carotenoid found in marine organisms,including salmon, shrimp, crustaceans, and algae such as Haematococcus pluvialis[17,18]. Accumulating evidence suggests that astaxanthin could prevent or even reverse NASH by improving oxidative stress,inflammation, lipid metabolism, insulin resistance and fibrosis.

    The objective of this review is to summarize the bio-functions of astaxanthin in the prevention of NASH.

    SOURCE, SYNTHETIC AND BIOLOGICAL ACTIVITY OF ASTAXANTHIN

    Astaxanthin is a secondary carotenoid with a chemical structure of 3,3’-dihydroxy-4,4’-diketo-β, β’-carotene,which is known for its strong antioxidant activity. It is widely found in nature, such as leaves, flowers, fruits,feathers of flamingos, most fishes, members of the frog family, crustaceans, and the unicellular alga,Haematococcus pluvialis, which is the most ideal source of natural astaxanthin[17,19]. At present, astaxanthin is mainly obtained by the biological extraction of aquatic products and by artificial synthesis from carotene as the raw material. Because synthetic astaxanthin is expensive and less natural than natural astaxanthin in terms of chemical safety and biofunctionality, currently astaxanthin is almost always obtained by biological extraction for its use as a dietary supplement.

    At present, astaxanthin is widely used in the food industry as a dietary supplement in a growing number of countries. In 1987, the US Food and Drug Administration (FDA) approved astaxanthin as a feed additive for animal and fish feed; in 1999, the FDA authorized it as a dietary supplement for humans[20]. Astaxanthin is lipophilic and hydrophilic, it is absorbed by intestinal epithelial cells in the small intestine and then esterified. It is passively diffused and combined with fat molecules. The unesterified part is combined with chylomicrons and then passed through the lymphatic system for transport into the liver. Spiller and Dewell[21]used a randomized, controlled, double-blind approach to assess the safety of oral administration of astaxanthin (6 mg/d) in healthy individuals. There was no significant difference in blood pressure and various biochemical parameters at 4 and 8 weeks. Humans cannot synthesize astaxanthin, and the ingested astaxanthin cannot be converted to vitamin A; excessive intake of astaxanthin will thus not cause hypervitaminosis A[22,23]. Astaxanthin has physiological functions such as inhibiting tumorigenesis,protecting the nervous system, preventing diabetes and cardiovascular diseases[17,24-27], and it is widely used in various industries such as food, cosmetics, health care products, and aquaculture. Considering the biological characteristics of astaxanthin and the complex pathogenesis of NASH, it remains unknown whether astaxanthin can be used to treat NASH; the underlying mechanism of action also remains obscured.

    Figure 1. Multiple-hit hypothesis of the progression of NAFLD/NASH. Dietary habits, environmental, and genetic factors cause overweight or obesity and change the intestinal microbiome. This results in increased serum FFA and inflammatory factor (adipo-, cytoand/or chemokines) levels and eventually leads to insulin resistance. Furthermore, insulin resistance leads to an increase in DNL in the liver and increases the synthesis and accumulation of TG and toxic levels of fatty acids. Fat accumulation in the liver in the form of TG leads to liver steatosis (NAFL). Free cholesterol and other lipid metabolites cause mitochondrial dysfunction and subsequent oxidative stress, and ROS release and ER stress further activates UPR; which collectively lead to hepatic inflammation and fibrosis (NASH).NAFLD: Nonalcoholic fatty liver disease; NASH: nonalcoholic steatohepatitis; FFAs: free fatty acids; DNL: de novo lipogenesis; LPS:lipopolysaccharide; TNFα: tumor necrosis factor alpha: IL-6: interleukin-6; TG: triglycerides; ER: endoplasmic reticulum; UPR: unfolded protein response; ROS: reactive oxygen species.

    THE MECHANISM OF ASTAXANTHIN IN THE PREVENTION OF NASH

    Anti-oxidative stress effect

    As stated above, oxidative stress is one of the various factors that contribute to the “multiple hits” in the pathogenesis of NASH and is the main contributor of liver injury and disease progression in NAFLD.Indeed, several oxidative stress biomarkers that have been determined in clinical models of NAFLD include nitric oxide (NO), lipid peroxidation products [lipid peroxides, thiobarbituric acid reactive substances(TBARS), Hydroperoxides, 8-isoprostane and 4-Hydroxynonenal], protein oxidation products (protein carbonyl, nitrotyrosine), DNA oxidation product (8-OH-dG), and CYP2E1[28,29]. Additionally, two clinical studies have found that increases in oxidative stressin vivo,measured by urinary 8-iso-prostaglandin F2α(8-iso-PGF2α), which is derived from the non-enzymatic oxidation of arachidonic acid and serum levels of soluble NOX2-derived peptide (sNOX2-dp), is an indicator of NOX2 activation, a NADPH oxidase isoform involved in ROS generation[30,31].

    Oxidative stress damage is due to the imbalance of oxidation and anti-oxidation processes in the body that cause tissue injury induced by excessive production of free radicals, ROS and reactive nitrogen species(RNS). Excessive ROS can react with proteins, lipids and DNA through a chain reaction, thereby destroying homeostasis and causing tissue damage[32,33]. However, studies have shown that ROS can be eliminated from their oxidative activity by antioxidants such as carotenoids. Carotenoids contain polyene chains and longchain conjugated double bonds, which are responsible for antioxidant activities, acting by quenching singlet oxygen to terminate the free radical chain reaction in the organism[34,35]. Astaxanthin, one of the most prominent carotenoids with antioxidant activity, can penetrate the whole cell membrane, reduce membrane permeability, and limit the entry of peroxide promoters such as hydrogen peroxide and tert-butyl hydroperoxide into the cell[36,37]. Thus, oxidative damage to pivotal molecules in cells can be prevented.Astaxanthin scavenges oxygen free radicals and prevents lipid auto-oxidation with a capacity that is 6,000 times greater than that of vitamin C, 800 times that of coenzyme Q10, 550 times that of vitamin E, 200 times that of tea polyphenols, and 10 times that of beta carotene[17,38]; rightfully therefore known as a “super antioxidant”. Jorgensenet al.[39]found that astaxanthin is more effective than beta-carotene and zeaxanthin in preventing excessive oxidation of unsaturated fatty acid methyl esters. This conclusion has also been verified in various biofilm models, including phosphatidylcholine liposomes[40]and rat liver microsomes[37].

    Nakagawaet al.[41]reported that supplementation with astaxanthin (6 and 12 mg/d) in 30 healthy subjects decreased erythrocyte phospholipid hydroperoxide (PLOOH) levels and increased astaxanthin levels, 12 weeks after administration. An animal study showed that the concentration of catalase (CAT), superoxide dismutase (SOD) and peroxidase (POD) increased significantly in the plasma and hepatocytes of rats that were fed Haematococcus pluvialis[42]. In obese and overweight adults, astaxanthin supplementation (5 and 20 mg/d) dramatically reduced the level of biomarkers related to oxidative stress, including malondialdehyde (MDA) and isoprostane, and increased SOD and total antioxidant capacity (TAC). These findings indicate the strong antioxidant capacity of astaxanthinin vivo[43].

    Anti-inflammatory effect and enhancement in M2 macrophage polarization

    Given the strong link between inflammation and oxidative stress, it is not surprising that astaxanthin has been studied as an agent to attenuate inflammation.In vitro, astaxanthin has been shown to reduce proinflammatory markers in several cell lines, such as rat alveolar macrophages[44], U937 cells[45], RAW 264.7 cells[46], Thp-1 cells[24], proximal renal tubular epithelial cells[47], HUVECs[48], and human lymphocytes[49].

    Wanet al.[50]demonstrated that M2 macrophage/Kupffer cells promote apoptosis in M1 macrophage/Kupffer cells and inhibit NAFLD progression. Astaxanthin restrains M1 macrophage/Kupffer cells and increases M2 macrophage/Kupffer cells, reducing liver recruitment of CD4+and CD8+cells and inhibiting inflammatory responses in NAFLD[51]. Inflammatory factors aggravate the progression of NAFLD; however, astaxanthin reduces the levels of interleukin (IL)-6 and tumor necrosis factor (TNF) α in the liver through proliferator-activated receptor α (PPARα) to alleviate inflammation[52]. When NASH was induced by diet, administration of natural astaxanthin (0.02%, ≈ 20 mg/kg BW) reduced liver inflammation and insulin resistance in C57BL/6J mice[51]. Compared to vitamin E, astaxanthin was more effective in preventing and treating NASH in this animal model[51].

    Recently, the gut-liver axis has been shown to mediate the NASH progression[53]. Notably, liver lipopolysaccharide (LPS) is produced by intestinal microbiota, which were known to induce oxidative stress and inflammation. The LPS/toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) signaling is critical for the activation of inflammatory pathways associated with NASH[54]. Lumenget al.[55]found that in primary macrophages and RAW 264.7 cells stimulated by LPS, astaxanthin significantly reduced the levels of NO, prostaglandin E2 (PGE2), TNFα, and IL-1β by inhibiting NF-κB activation. Macedoet al.[56]showed that astaxanthin can obviously reduce the production of proinflammatory cytokines, such as TNFα and IL-6, secreted by LPS-induced neutrophils and enhance the phagocytosis and bactericidal ability of neutrophils by inhibiting the production of O2-(superoxide anion radical) and H2O2.

    Improvement of mitochondrial respiratory chain

    Numerous studies have shown that excessive ROS can cause oxidative damage to mitochondria. In turn,damage to the mitochondrial respiratory chain complex I and III releases electrons to produce a large amount of ROS; approximately 90% of ROS in cells are produced from mitochondria. Superfluous ROS cause mitochondrial structural abnormalities and functional deficits, mainly manifested in decreased mitochondrial membrane potential, mitochondrial mutation, uncoupling of the mitochondrial respiratory chain, increased free radical production, and decreased adenosine triphosphate (ATP) production.Dysfunctional mitochondria trigger inflammatory cytokine production and often lead to the development of degenerative diseases, aging, metabolic diseases, cardiovascular diseases and so on.

    A growing body of studies has also involved astaxanthin in improving cellular mitochondrial oxidative respiratory chains to resist oxidative stress damage, and recent results hypothesize that astaxanthin has a“mitochondrial targeting” effect in cells. Fanet al.[57]verified that astaxanthin significantly attenuated homocysteine-induced cytotoxicity of H9C2 cells by inhibiting mitochondria-mediated apoptosis and blocked homocysteine-induced mitochondrial dysfunction by modulating the expression of the Bcl-2 family. Importantly, astaxanthin also significantly inhibits homocysteine-induced cardiotoxicityin vivoas well as improves angiogenesis. A similar study has shown that astaxanthin has the potential to reverse homocysteine-induced neurotoxicity and apoptosis by inhibiting mitochondrial dysfunction and ROSmediated oxidative damage and regulating the MAPK and AKT pathways[58]. After treatment of gastric epithelial cells with astaxanthin, Kimet al.[59]found that Helicobacter pylori-induced increases in ROS,mitochondrial dysfunction, NF-κB activation, and IL-8 expression were alleviated without affecting NADPH oxidase activity, indicating thereby that astaxanthin could prevent oxidative stress-mediated Helicobacter pylori infection that is associated with gastric inflammation Yuet al.[60]also found that astaxanthin can improve heat-induced skeletal muscle oxidative damage. In mouse C2C12 myoblasts exposed to heat stress at 43 ℃, astaxanthin lessened heat-induced ROS production in a concentrationdependent manner (1-20 μM), preventing mitochondrial disruption, depolarization and apoptotic cell death. Astaxanthin increases the protein expression of peroxisome proliferator-activated receptor γ coactivator-1β (PGC-1α) and mitochondrial transcription factor A (TFAM) at 37 ℃, and maintains mitochondrial tubular structure and a normal membrane potential (ΔΨm), i.e., maintainance of mitochondrial integrity and function. Data from Manoet al.[61]showed that astaxanthin inhibits oxidation and nitridation, which leads to apoptosis and lipid peroxidation of cytochrome c peroxidase, although its efficiency varies with membrane pH and lipid composition. It is hypothesized that astaxanthin is endowed with pH-dependent antioxidant/antiapoptotic properties in respiratory mitochondria. Astaxanthin and tocopherol nanoemulsions (NEs) were prepared using sodium caseinate (AS-AT/SC NEs) as a raw material to protect cells from ROS, oxidative stress, and mitochondrial membrane potential through mitochondriamediated apoptosis to prevent cell death, demonstrating therefore that apoptosis induced by AS-AT/SC NEs may be a potential method to destroy cancer cells[62]. Taken together, astaxanthin can ameliorate mitochondrial glutathione (GSH) activity, complex I activity, ATPase activity, mitochondrial membrane potential and fluidity by ROS, and excessively open the membrane permeability transition pore (MPTP)[63].

    Although an accurate discussion is lacking on the mechanisms by which mitochondria might assist in the prevention and treatment of NASH, the above studies suggest that mitochondrial function plays an indelible role in NASH.

    Lipid metabolism

    Jiaet al.[52]administered astaxanthin orally to C57BL/6J mice that were fed a high-fat diet for 8 weeks and found that astaxanthin could improve liver lipid accumulation and decrease liver TG levels. Astaxanthin was found to regulate PPAR levels. Activated PPARα increases liver fatty acid transport, metabolism, and oxidation levels; inhibits liver fat accumulation; induces hepatocyte autophagy; and cleaves lipid droplets through AMP-activated protein kinase/PGC-1α[64-66]. PPARα has become a key target for the treatment of NAFLD - activation of PPARγ regulates lipid synthesis-related gene expression and promotes fatty acid storage, and PPARγ overexpression induces hepatic lipid accumulation[67]. Astaxanthin activates PPARα,inhibits PPARγ expression, and reduces intrahepatic fat synthesis[63]. In addition, astaxanthin inhibits the AKT-mTOR pathway, which also causes autophagy of liver cells and breaks down lipid droplets stored in the liver[52]. Furthermore, astaxanthin reduces liver fatty acid synthesizing enzyme (FASN) mRNA levels and directly inhibitsde novosynthesis of fat[68].

    In vitroand clinical studies have shown that the continuous use of astaxanthin for 2 weeks can significantly prolong the oxidation time of low-density lipoprotein (LDL). Astaxanthin can inhibit the production of ox-LDL and the utilization of ox-LDL by the activation of macrophages along with the enhanced expression of PPARα. At the same time, it inhibits the expression of PPARγ and reduces the synthesis of fat in the liver.Augustiet al.[69]found that astaxanthin can significantly reduce oxidative stress damage and program lower blood lipid levels in rabbits with hypercholesterolemia. In patients with hypertriglyceridemia, serum TG levels of patients with long-term oral astaxanthin were significantly lower than those in the control group,while adiponectin and high-density lipoprotein (HDL) levels were significantly increased[70]. In obese and overweight people, oral astaxanthin lowers apolipoprotein B and LDL cholesterol levels and improves oxidative damage[43]. It has been reported that astaxanthin also reduces platelet aggregation and promote fibrinolytic activity in rats with hyperlipidemia induced by a high-fat diet. These positive effects are related to decreased serum lipid and lipoprotein levels, antioxidant production, and protection of endothelial cells[71].

    Amelioration of insulin resistance

    Insulin resistance is the major contributor to obesity, type 2 diabetes, and NAFLD. Insulin activates the tyrosine kinase activity of insulin receptor-beta (IRβ) subunits, which phosphorylates insulin receptor substrate, IRS, to activate the insulin metabolism pathway: IRS1-PI3K-AKT (insulin receptor substrate 1,phosphoinositide 3-kinase, serine/threonine kinase). When serine/threonine protein kinases, such as Jun Nterminal kinases (JNK) and mitogen-activated protein kinase 3 (ERK-1), inhibitors of nuclear factor kappa-B kinase (NF-κB) subunit beta (IKK-β), phosphorylate IRβ and IRS1, the IRS1-PI3K-AKT pathway is blocked and its activity decreases, and insulin resistance occurs accordingly[72,73]. The activation of JNK and NF-κB, stimulated by sustained endoplasmic reticulum (ER) stress also causes insulin resistance[74].Bhuvaneswariet al.[75,76]established a mouse model of type 2 diabetes induced by a high fructose-fat diet(HFFD) to study the effects of astaxanthin on hepatic insulin signaling and glucose metabolism.Astaxanthin intervention significantly improved insulin sensitivity in the HFFD group. This is because astaxanthin restores the insulin metabolic pathway by decreasing the activity of JNK and ERK-1 to ameliorate insulin resistance in the liver. Niet al.[51]constructed a diet-induced NASH mouse model that consisted of a high-fat, high cholesterol, and cholate diet (CL). In the fasting and fed states, glucose intolerance and hyperinsulinemia that accompanied the CL diet were significantly ameliorated by astaxanthin, and vitamin E treatment also reduced the plasma insulin levels to some extent. This result was related to the fact that astaxanthin-treated mice produced more insulin-stimulated phosphorylated IRβ and AKT than did control mice, while vitamin E had little effect on hepatic insulin signaling.

    Anti-fibrosis effect

    Hepatic fibrosis is a wound healing response characterized by excessive accumulation of extracellular matrix. Hepatic stellate cell (HSC) activation plays a key role in liver fibrosis[77]. Transforming growth factor beta 1 (TGF-β1) is the most effective profibrotic cytokine[78]. TGF-β1/Smad3 signaling regulates transcription of key genes in fibrosis, causing liver fibrosis. The imbalance in matrix metalloproteinases(MMPs) and MMP inhibitors (tissue inhibitor of MMPs, TIMPs) accelerates the progression of liver fibrosis, and TGF-β1 regulates the expression of MMPs and TIMPs. Yanget al.[79]confirmed that astaxanthin can reduce the expression of the TGF-β1-induced fibrosis genes α-SMA and Col1A1 and effectively inhibit fibrosis in LX-2 cells. The mechanism is that astaxanthin downregulates Smad3 phosphorylation and nuclear translocation induced by TGF-β1. Yanget al.[79]also observed that when activated primary HSCs were coincubated with astaxanthin, α-SMA mRNA and protein levels were significantly downregulated, indicating that astaxanthin can inhibit the early activation of resting HSCs.Shenet al.[80]studied the protective effect of astaxanthin on liver fibrosis induced by carbon tetrachloride(CCl4) and bile duct ligation. The results showed that astaxanthin effectively improved the pathological damage of liver fibrosis. Astaxanthin reduces the expression of TGF-β1 by downregulating nuclear NF-κB levels, maintains the balance between MMP2 and TIMP1, and inhibits the activation of HSCs and the formation of extracellular matrix (ECM). Hernandez-Geaet al.[81]reported that autophagic degradation of lipid droplets in HSCs provides energy for HSC activation, thereby aggravating the process of liver fibrosis.Astaxanthin alleviates HSC autophagy levels, reduces nutrient supply, and inhibits HSC activation. In addition, histone acetylation, as an epigenetic model, is involved in the activation of HSCs and the process of liver fibrosis[82]. Some studies have found that astaxanthin significantly suppresses the activation of HSCs by decreasing the expression of histone deacetylase 9 (HDAC9); HDAC3 and HDAC4 may also be involved in this process[74].

    Antitumor formation

    Hepatocellular carcinoma (HCC) is a malignant tumor with extremely high morbidity and mortality.Multiple signaling pathways, such as NF-κB p65, Wnt/beta-catenin, JAK/STAT, Hedgehog, Ras/MAPK and so on, are closely related to the development of liver cancer[83,84]. In the aflatoxin (AFB1)-induced liver cancer model, astaxanthin markedly reduced the number and size of liver cancer lesions. In-depth studies have found that astaxanthin significantly inhibits AFB1-induced single-strand DNA breaks and AFB1 binding to liver DNA and plasma albumin[85]. Tripathiet al.[86]found that astaxanthin inhibits cyclophosphamide-induced liver tumors in the early stage in rats. The Nrf2-ARE pathway is an endogenous antioxidant stress pathway that regulates the expression of SOD and DNA repair enzymes (e.g., OGG1,XRCC1, XPD, and XPG), which play an important role in tumorigenesis and progression[87,88]. Astaxanthin can inhibit the occurrence and development of liver cancer, which in turn, may be related to the activation of Nrf2-ARE pathway.

    Songet al.[89]confirmed that astaxanthin induces mitochondria-mediated apoptosis in the mouse liver cancer cell line CBRH-7919 by inhibiting the JAK/STAT3 pathway. In addition, astaxanthin inhibits liver tumorigenesis and may be involved in the regulation of NM23, which encodes a nucleoside diphosphate kinase. The upregulated expression of this protein is beneficial to the correct assembly of the cytoskeleton and the transmission of T protein signaling. Liet al.[90]confirmed that astaxanthin can prevent the proliferation of human hepatoma cells LM3 and SMMC-7721 and induce their apoptosis. The possible mechanism is that astaxanthin inhibits the NF-κB and Wnt/beta-catenin signaling pathways and regulates downstream the expression of the antiapoptotic protein, Bcl-2, and apoptosis-related gene, Bax; thereby promoting apoptosis of tumor cells. At the same time, astaxanthin decreases the phosphorylation of glycogen synthetase kinase-3 beta (GSK-3β) and inhibits tumor cell infiltration. Consistent with these findings, Shaoet al.[91]showed that astaxanthin can inhibit the proliferation of mouse hepatoma cell line H22 and arrest cells in the mitotic G2 phase.

    Figure 2. Mechanisms of the effects of astaxanthin on NASH. The strong antioxidant effect of astaxanthin can significantly inhibit oxidative stress, thereby reducing mitochondrial damage and endoplasmic reticulum stress, leading to a shift to M2 macrophage polarization and ultimately reversing liver steatosis, inflammation, and insulin resistance. Moreover, astaxanthin can reduce the activation of hepatic stellate cells to ameliorate hepatic fibrosis as a result of M1/M2 macrophage transformation. In addition,astaxanthin can inhibit the generation of hepatocyte tumors. Thus, astaxanthin prevents the development of NAFLD by inhibiting lipid accumulation, inflammation, and fibrosis in the liver. NAFLD: Nonalcoholic fatty liver disease; NASH: nonalcoholic steatohepatitis; KC:Kupffer cell; M1: proinflammatory macrophages; M2: anti-inflammatory macrophages; HSC: hepatic stellate cells; HCC: hepatocellular carcinoma.

    The increase inde novofat synthesis is a common feature of many malignant tumors. FASN is expressed in a variety of malignant tumors, including liver cancer[92,93], and astaxanthin downregulates liver FASN mRNA levels to restrain liver tumorigenesis[94]. In addition, adipocytokines, another key regulator of the fat synthesis pathway, play an important role in repressing the proliferation of human liver tumor cells and inducing apoptosis. Astaxanthin observably inhibits liver tumorigenesis in obese mice by increasing serum adipocytokine levels[95].

    CONCLUSION

    Astaxanthin has been recognized as a new food resource and is expected to have good application prospects in health food and dietary supplements. The prevalence of NASH continues to persist globally, and its complex and diverse pathogenesis makes it difficult to diagnose and treat. Currently, there are no FDAapproved standard drug regimens in the guidelines for management of NASH. At present, great progress has been made in researching the antioxidant activity of astaxanthin. A large number of studies have demonstrated that astaxanthin can prevent or treat NASH through various mechanisms [Figure 2]. Most studies on the influence of astaxanthin on NASH remain at the cellular and animal experiment level.However, the presented research in this work on the prevention and treatment of NASH by astaxanthin indicates that there is broad potential and hope for the application of astaxanthin in NASH. As a futuristic goal, we still need large-scale clinical trials to verify the actual effects of astaxanthin on the human body and provide a theoretical basis to continually explore the beneficial effects of astaxanthin antioxidant activity on the human body.

    DECLARATIONS

    Authors’ contributions

    Contributed to the drafting and writing of the manuscript: Gao LJ, Zhu YQ, Xu L

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    This study was supported by Xinmiao Talents Program of Zhejiang Province granted to L.G (2019R413070)and Wenzhou Municipal Science and Technology Bureau granted to L.X. (Y20190049).

    Conflicts of interest

    All authors declared that there are no conflicts of interest.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    ? The Author(s) 2021.

    精华霜和精华液先用哪个| 日韩在线高清观看一区二区三区| 日韩av免费高清视频| 国产一区有黄有色的免费视频 | 久久精品人妻少妇| 能在线免费观看的黄片| 在线 av 中文字幕| 一级毛片久久久久久久久女| 日韩电影二区| 床上黄色一级片| 日韩一区二区视频免费看| 亚洲av成人av| 国产高清三级在线| 777米奇影视久久| 中文字幕久久专区| 一边亲一边摸免费视频| av专区在线播放| 少妇的逼好多水| 国产又色又爽无遮挡免| 搡老乐熟女国产| 亚洲性久久影院| 国产视频首页在线观看| 97超碰精品成人国产| 视频中文字幕在线观看| 免费看光身美女| 久久6这里有精品| 成人亚洲精品一区在线观看 | 亚洲高清免费不卡视频| 最近中文字幕2019免费版| 最近手机中文字幕大全| 日本黄大片高清| 在线免费观看不下载黄p国产| 国产极品天堂在线| 成人二区视频| 日韩制服骚丝袜av| 国产亚洲av片在线观看秒播厂 | 久久精品人妻少妇| 久久韩国三级中文字幕| 人人妻人人澡人人爽人人夜夜 | 亚洲精品第二区| 亚洲乱码一区二区免费版| 国产v大片淫在线免费观看| 日韩精品有码人妻一区| 高清日韩中文字幕在线| 日本猛色少妇xxxxx猛交久久| 男女国产视频网站| 国产一区二区三区综合在线观看 | 91aial.com中文字幕在线观看| 18禁动态无遮挡网站| 色综合亚洲欧美另类图片| 夜夜爽夜夜爽视频| 狂野欧美激情性xxxx在线观看| 麻豆成人av视频| 久久午夜福利片| 边亲边吃奶的免费视频| 三级国产精品片| 亚洲av在线观看美女高潮| 少妇的逼水好多| 欧美激情在线99| 精品熟女少妇av免费看| 秋霞在线观看毛片| 日韩不卡一区二区三区视频在线| 天堂网av新在线| av在线天堂中文字幕| 亚洲av二区三区四区| 在线 av 中文字幕| 亚洲成人中文字幕在线播放| 午夜久久久久精精品| 久久久久久久午夜电影| 日韩一本色道免费dvd| 日韩av在线免费看完整版不卡| 精品酒店卫生间| 看黄色毛片网站| 亚洲国产精品国产精品| 干丝袜人妻中文字幕| 啦啦啦啦在线视频资源| 哪个播放器可以免费观看大片| videos熟女内射| 欧美性感艳星| 寂寞人妻少妇视频99o| 特大巨黑吊av在线直播| 九色成人免费人妻av| 九草在线视频观看| 国产精品美女特级片免费视频播放器| 97人妻精品一区二区三区麻豆| 婷婷六月久久综合丁香| 又大又黄又爽视频免费| 天天躁夜夜躁狠狠久久av| 91av网一区二区| 精品亚洲乱码少妇综合久久| 视频中文字幕在线观看| 亚洲精品日韩av片在线观看| 久久人人爽人人爽人人片va| 国产精品久久久久久av不卡| 草草在线视频免费看| 小蜜桃在线观看免费完整版高清| 午夜福利视频精品| 22中文网久久字幕| 精品亚洲乱码少妇综合久久| 97在线视频观看| 久久久久久久久久人人人人人人| 国产片特级美女逼逼视频| 国产不卡一卡二| 久久久欧美国产精品| 高清欧美精品videossex| av国产免费在线观看| 午夜视频国产福利| 免费观看的影片在线观看| 三级国产精品欧美在线观看| 春色校园在线视频观看| 网址你懂的国产日韩在线| 99热这里只有是精品在线观看| 日韩三级伦理在线观看| 国产毛片a区久久久久| 亚洲精品第二区| 亚州av有码| 黄色一级大片看看| 99热全是精品| 国产亚洲91精品色在线| 精品国产露脸久久av麻豆 | 蜜桃亚洲精品一区二区三区| 天堂√8在线中文| 免费av不卡在线播放| 国产单亲对白刺激| 久久久精品欧美日韩精品| 国产午夜福利久久久久久| 亚洲图色成人| 少妇猛男粗大的猛烈进出视频 | 夫妻午夜视频| 国产精品久久久久久久电影| 亚洲精品国产av蜜桃| 超碰av人人做人人爽久久| ponron亚洲| 国产成人精品一,二区| 亚洲高清免费不卡视频| 黄片wwwwww| 不卡视频在线观看欧美| 国产乱来视频区| 精品久久国产蜜桃| 日本-黄色视频高清免费观看| 亚洲人成网站在线播| 欧美一区二区亚洲| 久久精品人妻少妇| 精品一区二区三卡| 国产在视频线精品| 3wmmmm亚洲av在线观看| av在线亚洲专区| 99久久人妻综合| 午夜亚洲福利在线播放| 国产精品嫩草影院av在线观看| 97超视频在线观看视频| 国产白丝娇喘喷水9色精品| 久久精品久久久久久久性| 男女边吃奶边做爰视频| 亚洲av日韩在线播放| 午夜久久久久精精品| 91久久精品国产一区二区成人| 精品人妻视频免费看| 国产亚洲精品av在线| 最近的中文字幕免费完整| 欧美精品国产亚洲| 全区人妻精品视频| 亚洲精品一区蜜桃| 欧美日韩国产mv在线观看视频 | 欧美成人一区二区免费高清观看| 久久这里只有精品中国| 三级男女做爰猛烈吃奶摸视频| 国产91av在线免费观看| 一个人观看的视频www高清免费观看| 黄片wwwwww| 亚洲成色77777| 极品少妇高潮喷水抽搐| 少妇猛男粗大的猛烈进出视频 | 高清欧美精品videossex| 亚洲欧美清纯卡通| 国模一区二区三区四区视频| 国产精品久久视频播放| 国产在视频线精品| 天堂√8在线中文| 国产av在哪里看| 天天一区二区日本电影三级| 久久草成人影院| 国产成人a∨麻豆精品| 色吧在线观看| 欧美日韩综合久久久久久| 狂野欧美白嫩少妇大欣赏| 日韩不卡一区二区三区视频在线| 亚洲天堂国产精品一区在线| 亚洲最大成人手机在线| 久久久久久久国产电影| 亚洲av二区三区四区| 日日撸夜夜添| 免费观看的影片在线观看| 天堂网av新在线| 国产爱豆传媒在线观看| 久久精品综合一区二区三区| 亚洲欧美中文字幕日韩二区| 午夜免费观看性视频| 亚洲av国产av综合av卡| 国产精品精品国产色婷婷| 日本黄色片子视频| 日韩一区二区视频免费看| 国产爱豆传媒在线观看| 亚洲av福利一区| 精品欧美国产一区二区三| 久久久a久久爽久久v久久| 欧美xxⅹ黑人| 精品久久久久久久久av| 水蜜桃什么品种好| 日韩电影二区| 成人毛片a级毛片在线播放| av国产免费在线观看| 国产亚洲最大av| av国产久精品久网站免费入址| 精品久久久久久久久久久久久| 女人久久www免费人成看片| 亚洲欧美日韩无卡精品| 久久久精品欧美日韩精品| 国产成人aa在线观看| 日韩在线高清观看一区二区三区| 亚洲精品视频女| 国产高清国产精品国产三级 | 亚洲经典国产精华液单| freevideosex欧美| 激情五月婷婷亚洲| 能在线免费观看的黄片| videos熟女内射| 成年版毛片免费区| 黄片wwwwww| 午夜福利视频精品| 99热这里只有是精品50| 婷婷六月久久综合丁香| 国产一级毛片在线| 欧美精品一区二区大全| 插阴视频在线观看视频| 中文资源天堂在线| 男女边吃奶边做爰视频| 国产成人精品一,二区| 日本午夜av视频| 亚洲精品日本国产第一区| 岛国毛片在线播放| 成人漫画全彩无遮挡| 国产成人a区在线观看| 国产 一区精品| 午夜爱爱视频在线播放| 成年女人看的毛片在线观看| 免费观看无遮挡的男女| 内射极品少妇av片p| 又粗又硬又长又爽又黄的视频| 久热久热在线精品观看| freevideosex欧美| 日韩 亚洲 欧美在线| 成人亚洲精品一区在线观看 | 免费看a级黄色片| 亚洲av免费高清在线观看| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 亚洲久久久久久中文字幕| 亚洲精品日韩在线中文字幕| 男人爽女人下面视频在线观看| 成年版毛片免费区| 一区二区三区四区激情视频| 亚洲人成网站在线观看播放| 丰满人妻一区二区三区视频av| 久久精品久久久久久久性| 1000部很黄的大片| 毛片女人毛片| .国产精品久久| 久久人人爽人人爽人人片va| 欧美xxxx性猛交bbbb| 国产伦在线观看视频一区| 国产一区亚洲一区在线观看| 精品人妻一区二区三区麻豆| 久久精品久久久久久噜噜老黄| 在线免费十八禁| av天堂中文字幕网| 少妇猛男粗大的猛烈进出视频 | 国产三级在线视频| 一级黄片播放器| 免费观看在线日韩| 最后的刺客免费高清国语| 不卡视频在线观看欧美| 青青草视频在线视频观看| 国产淫语在线视频| 国产成人精品婷婷| 国产色婷婷99| 日韩三级伦理在线观看| 丝袜喷水一区| 久久久久久久久大av| 国产一级毛片在线| 国产 一区精品| 99热6这里只有精品| 国内精品美女久久久久久| 亚洲国产精品成人综合色| 97超碰精品成人国产| 国产国拍精品亚洲av在线观看| av线在线观看网站| 久久这里只有精品中国| 欧美高清性xxxxhd video| 国产黄频视频在线观看| 天堂俺去俺来也www色官网 | 国产精品嫩草影院av在线观看| .国产精品久久| 一区二区三区四区激情视频| 99re6热这里在线精品视频| 综合色av麻豆| 免费av观看视频| 又粗又硬又长又爽又黄的视频| 中文字幕人妻熟人妻熟丝袜美| 久久精品久久久久久噜噜老黄| 欧美丝袜亚洲另类| 2022亚洲国产成人精品| 久久久久性生活片| freevideosex欧美| 国产乱来视频区| 在线观看av片永久免费下载| 国产美女午夜福利| 日韩av在线免费看完整版不卡| 老司机影院成人| 夜夜看夜夜爽夜夜摸| 在线观看免费高清a一片| 亚洲,欧美,日韩| 嫩草影院精品99| 久久久精品免费免费高清| 亚洲精品色激情综合| 日本三级黄在线观看| av国产免费在线观看| 欧美丝袜亚洲另类| 亚洲精品久久久久久婷婷小说| 国产人妻一区二区三区在| 亚洲第一区二区三区不卡| 久久6这里有精品| 精品少妇黑人巨大在线播放| av在线播放精品| 日韩成人伦理影院| 综合色丁香网| 国产精品99久久久久久久久| 91在线精品国自产拍蜜月| 欧美人与善性xxx| 综合色av麻豆| 尾随美女入室| 校园人妻丝袜中文字幕| 欧美激情久久久久久爽电影| 视频中文字幕在线观看| 看免费成人av毛片| 毛片一级片免费看久久久久| 久久久久久久久久成人| 色吧在线观看| 建设人人有责人人尽责人人享有的 | 欧美高清性xxxxhd video| 一个人看的www免费观看视频| 菩萨蛮人人尽说江南好唐韦庄| 最近2019中文字幕mv第一页| 伊人久久精品亚洲午夜| 国产一区二区在线观看日韩| 亚洲精品日本国产第一区| 伊人久久精品亚洲午夜| 国产伦精品一区二区三区视频9| 男人爽女人下面视频在线观看| 少妇的逼水好多| 亚洲乱码一区二区免费版| 六月丁香七月| 网址你懂的国产日韩在线| 一二三四中文在线观看免费高清| 国产黄片美女视频| 国语对白做爰xxxⅹ性视频网站| 欧美日韩综合久久久久久| 亚洲国产最新在线播放| 午夜福利在线观看免费完整高清在| 亚洲综合精品二区| 1000部很黄的大片| 亚洲欧美中文字幕日韩二区| 国产黄色免费在线视频| 又爽又黄无遮挡网站| 深夜a级毛片| 婷婷色av中文字幕| 日韩精品有码人妻一区| 国产大屁股一区二区在线视频| 美女黄网站色视频| 免费人成在线观看视频色| 精品久久久久久久久av| 91精品一卡2卡3卡4卡| av在线天堂中文字幕| 国产伦在线观看视频一区| 综合色丁香网| 久久久久久久久久久免费av| 国模一区二区三区四区视频| 国产一级毛片七仙女欲春2| 久久久色成人| 亚洲精品乱码久久久久久按摩| 国产黄色视频一区二区在线观看| 最近手机中文字幕大全| 亚洲精品aⅴ在线观看| 国产亚洲av嫩草精品影院| 全区人妻精品视频| 简卡轻食公司| 国产黄频视频在线观看| 欧美极品一区二区三区四区| 亚洲欧美成人综合另类久久久| 直男gayav资源| 国产精品一及| 一级毛片aaaaaa免费看小| 2018国产大陆天天弄谢| 人人妻人人看人人澡| 18禁在线播放成人免费| 少妇高潮的动态图| 男插女下体视频免费在线播放| 高清午夜精品一区二区三区| 人妻少妇偷人精品九色| 只有这里有精品99| 久久久久久久国产电影| 亚洲一级一片aⅴ在线观看| 免费少妇av软件| 麻豆国产97在线/欧美| 免费看不卡的av| 成人漫画全彩无遮挡| 国产探花极品一区二区| videossex国产| 日本免费在线观看一区| 久久久久精品性色| 国产亚洲5aaaaa淫片| 一级av片app| 看非洲黑人一级黄片| 99久久人妻综合| 久久久久久久久久黄片| 赤兔流量卡办理| 国产综合精华液| 国产精品一区二区三区四区免费观看| 一本久久精品| 日韩av不卡免费在线播放| 成年免费大片在线观看| 在线观看一区二区三区| 中文在线观看免费www的网站| 精品午夜福利在线看| 日韩电影二区| 在线观看美女被高潮喷水网站| 看免费成人av毛片| 观看美女的网站| 亚洲人成网站在线观看播放| 免费电影在线观看免费观看| 久久精品国产鲁丝片午夜精品| 国产一区二区三区av在线| 亚洲人与动物交配视频| 天堂中文最新版在线下载 | 亚洲av男天堂| 欧美潮喷喷水| 在线观看美女被高潮喷水网站| 久久久久久久久久久免费av| 一区二区三区免费毛片| 男的添女的下面高潮视频| 成年免费大片在线观看| 日韩制服骚丝袜av| 啦啦啦韩国在线观看视频| 亚洲av电影在线观看一区二区三区 | 成人亚洲精品一区在线观看 | 国产国拍精品亚洲av在线观看| 免费看不卡的av| 亚洲av电影在线观看一区二区三区 | 在线a可以看的网站| 五月天丁香电影| 国产爱豆传媒在线观看| 一级av片app| www.色视频.com| 亚洲三级黄色毛片| 青青草视频在线视频观看| 国产白丝娇喘喷水9色精品| 亚洲四区av| 国产极品天堂在线| 国产中年淑女户外野战色| 久久久a久久爽久久v久久| 久久久久精品久久久久真实原创| 国产中年淑女户外野战色| 日本-黄色视频高清免费观看| 91精品伊人久久大香线蕉| 国产一区二区三区综合在线观看 | 久久草成人影院| 男人舔奶头视频| 中文乱码字字幕精品一区二区三区 | 久久久亚洲精品成人影院| 好男人视频免费观看在线| 亚洲,欧美,日韩| 大香蕉久久网| 男女边摸边吃奶| 美女cb高潮喷水在线观看| 99re6热这里在线精品视频| 五月玫瑰六月丁香| 伊人久久国产一区二区| 国产极品天堂在线| 亚洲精品国产av成人精品| 成人午夜精彩视频在线观看| 国产三级在线视频| 51国产日韩欧美| 精品酒店卫生间| 日韩强制内射视频| 联通29元200g的流量卡| 久久99热这里只有精品18| 九九爱精品视频在线观看| 两个人的视频大全免费| 一区二区三区免费毛片| 国产精品.久久久| 性插视频无遮挡在线免费观看| 九草在线视频观看| 欧美日韩视频高清一区二区三区二| 久久久久久久久中文| 日韩三级伦理在线观看| 蜜桃亚洲精品一区二区三区| 只有这里有精品99| 亚洲精品中文字幕在线视频 | 亚洲国产精品成人综合色| 精品熟女少妇av免费看| 免费看av在线观看网站| 99热网站在线观看| 午夜免费男女啪啪视频观看| 久久午夜福利片| 日韩av在线免费看完整版不卡| 成年av动漫网址| 一级a做视频免费观看| 欧美激情久久久久久爽电影| 日本欧美国产在线视频| 22中文网久久字幕| 秋霞在线观看毛片| 在线观看一区二区三区| 国产欧美日韩精品一区二区| 深爱激情五月婷婷| 欧美激情久久久久久爽电影| 久久午夜福利片| 国产黄色免费在线视频| 又爽又黄a免费视频| 搡老乐熟女国产| 精品不卡国产一区二区三区| 人妻系列 视频| 精品久久久久久电影网| 亚洲精品一二三| 18禁裸乳无遮挡免费网站照片| 免费高清在线观看视频在线观看| 亚洲av在线观看美女高潮| 91久久精品国产一区二区三区| 国产黄片美女视频| 非洲黑人性xxxx精品又粗又长| 97人妻精品一区二区三区麻豆| 午夜久久久久精精品| 久久久久久久午夜电影| 久久久久久久久久久免费av| 亚洲成人久久爱视频| 亚洲精品成人久久久久久| 久久精品国产亚洲av天美| 国产成人精品婷婷| 亚洲在久久综合| 亚洲精品国产av成人精品| 午夜日本视频在线| 熟妇人妻不卡中文字幕| 床上黄色一级片| 不卡视频在线观看欧美| 国产亚洲av嫩草精品影院| 免费高清在线观看视频在线观看| 国产久久久一区二区三区| 国产国拍精品亚洲av在线观看| 欧美人与善性xxx| 亚洲va在线va天堂va国产| 在线观看av片永久免费下载| 亚洲av电影不卡..在线观看| 久久人人爽人人爽人人片va| 国产探花极品一区二区| 毛片女人毛片| 日韩欧美精品v在线| 精品久久久久久久久久久久久| 欧美另类一区| 白带黄色成豆腐渣| 国产精品一区www在线观看| 97人妻精品一区二区三区麻豆| av在线老鸭窝| 嫩草影院新地址| av在线蜜桃| 久热久热在线精品观看| 亚洲国产欧美在线一区| 一个人看视频在线观看www免费| 午夜福利视频1000在线观看| 亚洲精品久久久久久婷婷小说| 国产在线一区二区三区精| 夫妻午夜视频| 国产黄片美女视频| 狂野欧美白嫩少妇大欣赏| 亚洲欧美成人综合另类久久久| 波多野结衣巨乳人妻| 午夜福利视频精品| 国产乱人视频| 精品久久久久久成人av| 国产精品三级大全| 看十八女毛片水多多多| 日韩 亚洲 欧美在线| 搡女人真爽免费视频火全软件| av专区在线播放| 91精品伊人久久大香线蕉| freevideosex欧美| 精品久久久久久久久久久久久| 搡老乐熟女国产| 精品国产露脸久久av麻豆 | 亚洲av二区三区四区| 秋霞在线观看毛片| 亚洲av男天堂| 日韩成人伦理影院| 婷婷色综合www| 亚洲精品成人久久久久久| 联通29元200g的流量卡| 免费观看无遮挡的男女| 午夜福利高清视频| av黄色大香蕉| 欧美一区二区亚洲| 欧美xxⅹ黑人| 久热久热在线精品观看| 一边亲一边摸免费视频| 国产精品.久久久| 午夜激情福利司机影院| 丰满人妻一区二区三区视频av| 亚洲,欧美,日韩| 好男人在线观看高清免费视频|